Patient-focused studies advance progress towards global clinical trials on Khiron strains to treat inflammation, oxidative and nervous system disorders Co-sponsored with Uruguay government using Company strains, 18-month studies represent one of the most significant private-public medical...
from PR Newswire: https://ift.tt/2yq2T4Z